论文部分内容阅读
作者为了解当前美国主要大城市执行全国制定的结核病诊断和化疗的实施情况,函询了28个大城市卫生部门的防痨官员有关现行肺结核的诊断化疗方法,如初治肺结核化疗方案,短程化疗和间歇化疗的实施情况,初治病例的住院适应症及其所占比重,化疗期间和化疗结束后的管理随访等。本文根据回答问题90％以上的27份复函整理,因而可以反映当前美国防痨工作的实际情况,主要结果如下: 执行全国方案规定,对疑似肺结核检验痰菌4～6次者只有7处占26％,而在全部疗程中验痰的有24处达92％,即使痰菌已经阴转亦如此。作者指出芝加哥和旧金山的医院,验痰(涂片及培养)一次平均45元。初治病例最多用1NH+EB或INH+RFP治疗。用INH+EB+RFP方案的
In order to understand the current implementation of TB diagnosis and chemotherapy in major cities in the United States, the authors consulted anti-tuberculosis officials in 28 metropolitan health departments about diagnostic and therapeutic strategies for TB, such as initial treatment of tuberculosis and chemotherapy, short-course chemotherapy and The implementation of intermittent chemotherapy, hospital-based indications and the proportion of newly diagnosed cases, chemotherapy and chemotherapy after the end of management follow-up. According to the reply of more than 90% of the 27 replies, this article can reflect the current actual situation of American anti-tuberculosis work. The main results are as follows: The implementation of the national program stipulates that only 4 of 6 sputum suspected pulmonary tuberculosis 26%, whereas in 24 of the whole course of treatment sputum reached 92%, even if sputum had been negative also so. The authors point out that an average of 45 yuan per sputum (smear and culture) at Chicago and San Francisco hospitals. Newly treated cases up to 1NH + EB or INH + RFP treatment. With INH + EB + RFP program